Publication | Closed Access
EGFR–Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase Inhibitors
73
Citations
14
References
2016
Year
MedicineReceptor Tyrosine KinaseCancer GeneticsPharmacologyCell BiologyEgfr–co-mutated Advanced NsclcNovel TherapyMolecular OncologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1